chrisvoncsefalvay/vaers-outcomes huggingface dataset:
pain in her arm which travelled to her neck and jaw; Parotid gland was clogged; parotid gland was swollen; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 08-Apr-2021 and was forwarded to Moderna on 08-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain in her arm which travelled to her neck and jaw), PAROTID GLAND ENLARGEMENT (Parotid gland was clogged) and NONINFECTIVE SIALOADENITIS (parotid gland was swollen) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010A21A and 045A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No Medical history reported.).   On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 15-Mar-2021, the patient experienced PAIN IN EXTREMITY (pain in her arm which travelled to her neck and jaw), PAROTID GLAND ENLARGEMENT (Parotid gland was clogged) and NONINFECTIVE SIALOADENITIS (parotid gland was swollen). At the time of the report, PAIN IN EXTREMITY (pain in her arm which travelled to her neck and jaw), PAROTID GLAND ENLARGEMENT (Parotid gland was clogged) and NONINFECTIVE SIALOADENITIS (parotid gland was swollen) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. Doctors mentioned that events happened randomly and has nothing to do with the vaccine. Patient was treated with Tylenol.   This case was linked to MOD-2021-071497 (Patient Link).
Irregular bowel movements from prior to vaccine.  Consistency, color and odor of stools changed.  Patient is exclusively breastfed prior stools had light odor and were yellow seedy.  Following vaccine the stools were every 3rd day,  foul smelling and dark green in color with no seed consistency.  Additionally patient had foul smelling gas.
Pt recvd 3 doses of Engerix-B: titer test indicated did not respond;
pt recv vax 30OCT95 & pt may have inadvertently recv inj IV as there was some blood in the syringe when aspirating;pt devel sl head pressure & dizziness which resolved;pt's BP was 140/58,pulse was 100
HPI Had exposure from grand child was feverish but also was at a meeting a week ago with a lady who later turned positive  Over weekend fever, chills , fatigue and nasal congestion started  Received pfjzer vaccine 6 mo ago  Is having shortness of breath  Dry cough The following portions of the patient's history were reviewed and updated as appropriate: allergies, current medications, past family history, past medical history, past social history, past surgical history and problem list.
This spontaneous report was received from a physician concerning multiple unspecified patients of unknown age and gender. The patients' medical history, concurrent conditions, drug reactions/allergies and concomitant medications were not reported. On unknown dates, the patients were vaccinated with improperly stored doses of VAQTA lot # M034893, expiration date: 26-MAY-2017, via intramuscular, as prophylaxis (Strength and dose were not reported), which experienced a temperature excursion between 46 and 77 Fahrenheit degrees for 24 hours and between 32 and 36 Fahrenheit degrees for 419 hours and 30 minutes. There were no previous temperature excursions. Digital data logger was not involved. It was also reported that the patients were vaccinated with improperly stored doses of VAQTA via intramuscular as prophylaxis (Strength, lot #, expiration date and dose were not reported), which experienced an unknown temperature excursion for an unknown time frame. There were no previous temperature excursions. Digital data logger was not involved. No adverse effects were reported.   A product quality complaint was not involved. This is one of two reports received from the same reporter. Additional information has been requested.; Sender's Comments: US-009507513-1701USA014312:
Approximately 2 hours following the patient's first dose of Pfizer Covid-19 vaccine the patient experienced an anaphylactic reaction. She had hives, face swelling, and throat closing symptoms. She visited a local hospital emergency department for treatment including epinephrine.
APPROXIMATELY  15 MINUTES AFTER MODERNA DOSE #1 PATIENT COMPLAINED OF HEAD FEELING DIZZY, METALLIC TASTE IN MOUTH AND NUMBNESS TO THROAT.  THEN PATIENT SAID THROAT FELT "TIGHT".  EPI AND BENADRYL IM WAS ADMINISTERED ON SITE. PATIENT REPORTS FEELING SOME RELIEF AFTER BEING DOSED.  PATIENT WAS TRANSPORTED VIA EMS TO HOSPITAL
Pt. had Varicella Vaccine & Hep. B Vaccine @ 0910am. While attempting to sit in waiting room she stated she felt funny like she was going to pass out. She went forward & hit her L Forehead on the wall. Was then assisted into chair. Rescue called, At that time she was disoriented, weak, pale & diaphoretic. She was able to answer what her name is. She then slumped over, became unresponsive for a few seconds...increased diaphoresis, noted that hands became clenched. Smelling Salts administered, ice pack applied to back of neck. Pt became responsive, able to answer questions appropriately. Pupils dilated to approx. 14mm. VS P-60, RR-12, BP-101/49, O2 Sat 97%. Rescue arrived, VSS,PERRLA @ 6mm, she stated she felt better and initially declined transport to ED. While waiting for ride...she stated that she was feeling worse & that her vision was "Wavy/Blurry" similar to an "Aura" she has had in the past with Migraines. Pupils again dilated to approx. 10mm. Denied headache & nausea. Rescue again called & she was transported to ED.
Rash to back, chest, antecubital area, face 5 minutes after flu shot administration.
Intense body aches; Muscles were rigid; Fever and severe headaches; Fever and severe headaches; Covid-19 like symptoms; Laid up for 36 hours; This spontaneous case was reported by a physician and describes the occurrence of MYALGIA (Intense body aches), MUSCLE RIGIDITY (Muscles were rigid), PYREXIA (Fever and severe headaches), HEADACHE (Fever and severe headaches) and COVID-19 (Covid-19 like symptoms) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2021, the patient experienced MYALGIA (Intense body aches), MUSCLE RIGIDITY (Muscles were rigid), PYREXIA (Fever and severe headaches), HEADACHE (Fever and severe headaches), COVID-19 (Covid-19 like symptoms) and SOMNOLENCE (Laid up for 36 hours). On 24-Feb-2021, MYALGIA (Intense body aches), MUSCLE RIGIDITY (Muscles were rigid), PYREXIA (Fever and severe headaches), HEADACHE (Fever and severe headaches), COVID-19 (Covid-19 like symptoms) and SOMNOLENCE (Laid up for 36 hours) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 19-Nov-2021, SARS-CoV-2 test: positive (Positive) positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Lab test : IgG antibody test - positive  Concomitant product use was not reported  Treatment information was not provided
Hands trembling / shaking; This case was received (Reference number: 2021-001169) on 12-Aug-2021 and was forwarded to Moderna on 12-Aug-2021.    This spontaneous case was reported by a consumer and describes the occurrence of TREMOR (Hands trembling / shaking) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Penicillin allergy.    On 08-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Aug-2021, the patient experienced TREMOR (Hands trembling / shaking). On 12-Aug-2021, TREMOR (Hands trembling / shaking) was resolving.            No concomitant medication was provided  Treatment medication was not provided by the reporter
On April 28th they went the the doctor was thinking maybe a pinched nerve, on April 14th the went to the office the doctor wanted to conduct a nerve test. April 15th got a MRI done. Then April 18th got sent to the  neurologist the have a MRI with contrast. The doctor is thinking it could possibly be ALC
This case was reported by a nurse and described the occurrence of dizziness in a 19-year-old female patient who received BEXSERO (batch number 156701, expiry date 1st August 2017). On 24th July 2017, the patient received the 1st dose of BEXSERO. On 25th July 2017, 1 days after receiving BEXSERO, the patient experienced dizziness, sore throat, general body pain and fever. The patient was treated with Lorazepam and fentanyl. On an unknown date, the outcome of the dizziness, sore throat, general body pain and fever were recovered/resolved. The reporter considered the dizziness, sore throat, general body pain and fever to be probably related to BEXSERO. Additional details were provided as follows: The patient in the clinic had an anaphylactic reaction to the MenB vaccine. The incident happened a month ago and was not an anaphylactic reaction. On 25th July 2017, the body temperature was recorded as 104F. The patient was treated with Fentanyl and Lorazepam and the symptoms subsided. The patient required emergency room visit and had a spinal tap in the emergency room, but was not hospitalized.
Less than 1 minute after administering DTaP, Hep A and Hep B vaccines the patient had stiffening of his entire body with laryngospasm which lasted aprox. 5 seconds.  He did not lose consciousness but became pale.  After lying down for a few minutes he recovered completely.  He had not eaten breakfast prior to visit.
On 7/24/01, pt developed a fever of 104.1F. Had a fever between 102.9F and 104F for 2 days. Also had scattered papular rash on trunk on 7/26/01.
Mild pain at injection site; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 49 year-old male patient received bnt162b2 (BNT162B2), administration date 2021 (Lot number: EN5318) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VACCINATION SITE PAIN (non-serious) with onset 2021, outcome "unknown", described as "Mild pain at injection site".  No follow-up attempts are possible. No further information is expected.
sore arm, tingling in fingers, joint pain, increased back pain (chronic), felt like had something stuck in throat, chills, increased headaches (chronic headaches) Patient had recent back surgery, has chronic pain and chronic headaches but states they were more like a migraine
02/06/2021 PASSED OUT, AMBULENCE SUMMONED, OVERNIGHT STAY, HEALTH CENTER.
Around 8pm that evening after receiving the vaccine, she started to get a headache, chills and body aches.  Throughout the night those symptoms got worse.  Had a severe headache, chills and body aches.  Compared the symptoms to having influenza.  By mid afternoon of that next day her symptoms started to fade.
Information has been received from a physician concerning a 5 year old male who on 11/8/99 was vaccinated with a dose of varicella virus vaccine live. The physician reported that on 9/27/04 the patient was seen due to breakthrough varicella characterized by 70 to 80 lesions on his abdomen, arms and legs. The patient was treated with acyclovir. At the time of this report, the outcome was unknown. Additional information has been requested.
2+ weeks following vaccination, patient reports right arm pain, numbness, tingling, and right hand numbness.
Fever the day after being vaccinated. Then a steady progression of events: swollen glands, muscle aches, muscle weakness, fatigue,  internal vibrations, heart palpitations, and pericarditis.
About 7 minutes post vaccine patient turned pale, started having dizziness- laid patient down on ground, placed cool cloth on face and neck, took BP 99/61 (which husband and patient states are normal for her).  After a few minutes patient was feeling ok.
Red Spot; Hot; swollen; itchy; Raised tattoo edges.; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE ERYTHEMA (Red Spot), INJECTION SITE WARMTH (Hot), INJECTION SITE SWELLING (swollen), INJECTION SITE PRURITUS (itchy) and SWELLING (Raised tattoo edges.) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 15-Mar-2021, the patient experienced INJECTION SITE ERYTHEMA (Red Spot), INJECTION SITE WARMTH (Hot), INJECTION SITE SWELLING (swollen), INJECTION SITE PRURITUS (itchy) and SWELLING (Raised tattoo edges.). At the time of the report, INJECTION SITE ERYTHEMA (Red Spot), INJECTION SITE WARMTH (Hot), INJECTION SITE SWELLING (swollen), INJECTION SITE PRURITUS (itchy) and SWELLING (Raised tattoo edges.) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
her arm was also red almost like a rash; very sore arm; her arm was also red almost like a rash; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (her arm was also red almost like a rash), PAIN IN EXTREMITY (very sore arm) and RASH (her arm was also red almost like a rash) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination.     The patient's past medical history included Hashimoto's disease (She has a history of Hashimoto's disease.).    On 29-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ERYTHEMA (her arm was also red almost like a rash), PAIN IN EXTREMITY (very sore arm) and RASH (her arm was also red almost like a rash). The patient was treated with ACETAMINOPHEN at an unspecified dose and frequency. At the time of the report, ERYTHEMA (her arm was also red almost like a rash), PAIN IN EXTREMITY (very sore arm) and RASH (her arm was also red almost like a rash) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No concomitant medication information was provided.  It was reported that patient took acetaminophen and events dissipated within 24 hours.   This case was linked to MOD-2022-537593, MOD-2022-537594 (Patient Link).
This spontaneous report was received from a 25-year-old female patient, who referred to herself. The patient's concurrent conditions included anxiety and depression. The patient was allergic to amoxicillin (+) clavulanate potassium (AUGMENTIN), sulfacetamide sodium (+) sulfadiazine (+) sulfamethazine (SULFA) and latex. On unknown dates in 2006, the patient received three doses of GARDASIL intramuscularly (lot# and expiration dates were not reported) as prevention of human papilloma virus (HPV). Concomitant medications included citalopram. On an unknown date in 2015, reported as approximately two years ago, the patient was diagnosed with an unspecified type of HPV. It was also reported, that on an unknown date, the patient had an abnormal pap smear. No treatment was provided for the events. The patient sought medical attention by contacting her physician. At the time of the report the patient did not recover from the reported events. No product quality complaint was involved. The relatedness between the events and the suspect therapy was not reported.
Information has been received regarding a case in litigation, from a lawyer, concerning a patient of unknown age and gender. Information regarding the patient's pertinent medical history, concurrent conditions, known allergies and concomitant medications was not provided. In 2013, the patient was vaccinated with ZOSTAVAX (strength, dose, anatomical route of vaccination, lot # and expiration date were not provided) for prophylaxis. On an unknown date, the patient was diagnosed with shingles and / or other zoster-related injuries after and, despite being inoculated with the ZOSTAVAX (shingles and vaccination failure). Due to the patient's shingles, on 10-DEC-2016, the patient was treated by a healthcare provider. Furthermore, it was reported that the patient suffered serious physical, emotional and economic damages as a result. The patient would continue to suffer ongoing injuries, included but not limited to: mental and physical pain and suffering (emotional distress and pain), extensive medical care and treatment for these injuries, significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs including care for hospitalization, physician care, monitoring, treatment, medications and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of pre-existing conditions and activations of latent conditions, lost wages, loss of earning capacity and other losses and damages. At the time of report, the outcome of emotional distress and pain was reported as not recovered and the outcome of the patient regarding the vaccination failure, herpes zoster, quality of life decreased, and the pre-existing unspecified conditions aggravated was unknown. Additionally, the reporter considered herpes zoster, condition aggravated, quality of life decreased, pain, emotional distress and vaccination failure to be related to ZOSTAVAX. The reporter considered the events to be serious due to disabling, life-threatening, hospitalization and medically significant.
This spontaneous report as received from a Certified Medical Assistant refers to a patient of an unknown age and gender. On an unknown date, the patient was vaccinated with GARDASIL 9 prefilled syringe, intramuscular (strength, dose, dose number and frequency were not reported). It was reported, that prefilled syringe "leaked from opposite side during injection" by physician. No adverse effects reported. The reporter stated, that injection was completed using another GARDASIL 9 prefilled syringe. Additional information has been requested.
Joint swelling in hands three days after shot. Joint swelling and pain in big toe of right foot.
covid; feeling ill; Initial information was received on 10-Feb-2021 regarding an unsolicited valid non-serious case from a consumer or non-health care professional.  This case involves a female patient (age unspecified) who experienced Corona virus disease (COVID-19), after she received INFLUENZA VACCINE.  It was unknown if the patient had any medical history, concomitant disease or risk factor. Past medical treatment, vaccination, family history and concomitant medication were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE (produced by unknown manufacturer) [lot number, expiry date and other dosing details were not reported] for prophylactic vaccination.  On an unknown date, the patient developed a non-serious ill feeling (malaise), (unknown latency) following the administration of INFLUENZA VACCINE and 1 week later patient tested positive for COVID (COVID-19).   It was unknown if the patient experienced any additional symptoms/events.  Relevant laboratory test results included: SARS-CoV-2 test - On an unknown date: Positive  It was unknown if there were lab data/results available.  It was not reported if the patient received any corrective treatment.  At the time of reporting, event outcome was not reported for reported events.
pt recvd vax & devel sore on buttock; pt also felt sleepy for 1 wk & was cranky;
Woke from sleep at 3:00AM with terrible aches throughout muscles and joints.  Difficult to get out of bed; pain started subsiding 3 to 4 PM following day and  following morning was able to eat breakfast and move about.    I experienced same symptoms after second injection; however they only lasted almost exactly 12 hours.  This third injection lasted nearly 36 hours.
On 9/5/2012 patient called that he had body aches & might feel temperature. Today he showed up swelling in his arm up to elbow. The arm was red too.
Narrative:  hospitalized 4-6 for hypoxemia and covid positive in setting of significant HFpEF
low-grade fever; This case was reported by a consumer via interactive digital media and described the occurrence of fever in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included allergic reaction (some allergy reaction on hands that would come and go and would travel further every time it happened).   In May 2022, the patient received the 1st dose of Shingles vaccine. In May 2022, less than 2 weeks after receiving Shingles vaccine, the patient experienced fever. On an unknown date, the outcome of the fever was unknown.   It was unknown if the reporter considered the fever to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 15-May-2022 Reporter's Comments: This case was reported by the patient via interactive digital media. The patient kept having some allergy reaction on his/her hands that would come and go and would travel further every time it happens, so the patient scared himself/ herself into starting the shingles shot. The patient thought it might have been the shingles trying to start, but though it was some allergy reaction. The patient had one shot last week from reporting date and would have the other one in two months. The patient stated that he/she needed the shot anyway, but he/she did not like the low-grade fever that came with it, his/ her body did not like shots. Additional Supportive Information: The follow-up would not be possible as no contact details were available.
Pain in my arm,  pain in the injection side, redness and swollen, and hot to touch. Muscle pain and I cannot elevate my arm. Wake up every night from the pain in my arm and side. Pain in my armpit area, but not swollen. I have these symptoms until today.  That is why I am reporting. My blood work was done 2 days ago and my white blood cells count is lower than normal.  3.5
Cellulitis of right arm-raised, red warm to touch area from right shoulder to right elbow.  Cellulitis noted both on outer and inner part of right upper arm. No fever
This spontaneous report was received from a medical assistant referring to an unspecified number of patients of unknown age and gender. The patients' medical history, concurrent conditions, concomitant medications, and historical drugs were not reported. On unknown dates, the patients were vaccinated with improperly stored doses of VARIVAX with lot #s M038856, expiration date 14-SEP-2018, and  N019839 and expiration date 13-JUL-2018 (route, dose, dose number, frequency and anatomical location were unknown); and doses of  PROQUAD with lot #s N020007 and expiration date 13-JAN-2019; N021726 and expiration date 06-FEB-2019; N014950 and expiration date 11-NOV-2018, and N020008 and expiration date 13-JAN-2019  (route, dose, dose number, frequency and anatomical location were unknown) for prophylaxis reconstituted with properly stored sterile diluent(MERCK STERILE DILUENT). Administered doses of vaccines experienced the temperature excursion of -14 C to-10 C degrees Celsius for 21 minutes. There was no adverse effect reported. A Data digital  logger was involved, and there were no previous excursions reported.